A modulatory interleukin-10 response to staphylococcal peptidoglycan prevents Th1/Th17 adaptive immunity to Staphylococcus aureus

Journal of Infectious Diseases

Volumn 204, Issue 2, 2011, Pages 253-262

  Frodermann, Vanessa ^a,b   Chau, Thu A ^a   Sayedyahossein, Samar ^a   Toth, Judit M ^a,c   Heinrichs, David E ^a   Madrenas, Joaquín ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b LEIDEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; APC PROTEIN; CD14 ANTIGEN; CD36 ANTIGEN; DIMETHYL SULFOXIDE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; PEPTIDOGLYCAN; PHOSPHATIDYLINOSITOL 3 KINASE; TOLL LIKE RECEPTOR 2; WORTMANNIN;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; DRUG INHIBITION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MONOCYTE; PLASTICITY; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL;

ADAPTIVE IMMUNITY; ELAFIN; HUMANS; INTERLEUKIN-10; MACROPHAGES; MONOCYTES; PEPTIDOGLYCAN; STAPHYLOCOCCUS AUREUS; TH1 CELLS; TH17 CELLS; TOLL-LIKE RECEPTOR 2;

EID: 79958742164     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir276     Document Type: Article

References (45)

1. Mele T, Madrenas J. TLR2 signalling: at the crossroads of commensalism, invasive infections and toxic shock syndrome by Staphylococcus aureus. Int J Biochem Cell Biol 2010; 42:1066-1071.
2. Ip WK, Sokolovska A, Charriere GM, et al. Phagocytosis and phagosome acidification are required for pathogen processing and MyD88-dependent responses to Staphylococcus aureus. J Immunol 2010; 184:7071-7081.
3. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783-801. (Pubitemid 43261452)
4. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140:805-820.
5. Roy CR, Mocarski ES. Pathogen subversion of cell-intrinsic innate immunity. Nat Immunol 2007; 8:1179-1187. (Pubitemid 350019233)
6. McCully ML, Fairhead T, Blake PG, Madrenas J. The future of RIP2/RICK/CARDIAK as a biomarker of the inflammatory response to infection. Expert Rev Mol Diagn 2008; 8:257-261. (Pubitemid 351724705)
7. Manicassamy S, Pulendran B. Modulation of adaptive immunity with Toll-like receptors. Semin Immunol 2009; 21:185-193.
8. Netea MG, Sutmuller R, Hermann C, et al. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 2004; 172:3712-3718. (Pubitemid 38337955)
9. Sutmuller RP, den Brok MH, Kramer M, et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 2006; 116:485-494. (Pubitemid 43228366)
10. Manicassamy S, Ravindran R, Deng J, et al. Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nat Med 2009; 15:401-409.
11. Re F, Strominger JL. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 2001; 276:37692-37699.
12. Dillon S, Agrawal S, Banerjee K, et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J Clin Invest 2006; 116:916-928.
13. Chau TA, McCully ML, Brintnell W, et al. Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T-cell activation and prevent toxic shock syndrome. Nat Med 2009; 15:641-648.
14. Lai Y, Di Nardo A, Nakatsuji T, et al. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat Med 2009; 15:1377-1382.
15. Duthie ES, Lorenz LL. Staphylococcal coagulase: mode of action and antigenicity. J Gen Microbiol 1952; 6:95-107.
16. Li H, Nooh MM, Kotb M, Re F. Commercial peptidoglycan preparations are contaminated with superantigen-like activity that stimulates IL-17 production. J Leukoc Biol 2008; 83:409-418. (Pubitemid 351225622)
17. Bueno C, Lemke CD, Criado G, et al. Bacterial superantigens bypass Lck-dependent T cell receptor signaling by activating a Galph a11-dependent, PLC-beta-mediated pathway. Immunity 2006; 25:67-78. (Pubitemid 44066827)
18. Schroder K, Tschopp J. The inflammasomes. Cell 2010; 140:821-832.
19. Travassos LH, Girardin SE, Philpott DJ, et al. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep 2004; 5:1000-1006. (Pubitemid 39534459)
20. Hazeki K, Nigori K, Hazeki O. Role of phosphoinositide 3-kinase in innate immunity. Biol Pharm Bull 2007; 30:1617-1623. (Pubitemid 47403233)
21. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010; 327:291-295.
22. Barbalat R, Lau L, Locksley RM, Barton GM. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat Immunol 2009; 10:1200-1207.
23. Jang S, Uematsu S, Akira S, Salgame P. IL-6 and IL-10 induction from dendritic cells in response to Mycobacterium tuberculosis is predominantly dependent on TLR2-mediated recognition. J Immunol 2004; 173:3392-3397. (Pubitemid 39142049)
24. Re F, Strominger J. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J Immunol 2004; 173:7548-7555. (Pubitemid 39628196)
25. Ardura MI, Banchereau R, Mejias A, et al. Enhanced monocyte response and decreased central memory T cells in children with invasive Staphylococcus aureus infections. PLoS One 2009; 4:e5446.
26. Gillrie MR, Zbytnuik L, McAvoy E, et al. Divergent roles of Toll-like receptor 2 in response to lipoteichoic acid and Staphylococcus aureus in vivo. Eur J Immunol 2010; 40:1639-1650.
27. Akashi-Takamura S, Miyake K. TLR accessory molecules. Curr Opin Immunol 2008; 20:420-425.
28. Fukao T, Tanabe M, Terauchi Y, et al. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat Immunol 2002; 3:875-881.
29. Martin M, Rehani K, Jope RS, Michalek SM. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 2005; 6:777-784. (Pubitemid 43090463)
30. Martin M, Schifferle RE, Cuesta N, Vogel SN, Katz J, Michalek SM. Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide. J Immunol 2003; 171:717-725. (Pubitemid 36871381)
31. Polumuri SK, Toschchakov V, Vogel SN. Role of phosphatidylinositol-3 kinase in transcriptional regulation of TLR-induced IL-12 and IL-10 by Fcγ receptor ligation in murine macrophages. J Immunol 2007; 179:236-246. (Pubitemid 46986539)
32. Arbibe L, MiraTeusch JP, Teusch N, et al. Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol 2000; 1:533-540.
33. Santos-Sierra S, Deshmukh SD, Kalnitski J, et al. Mal connects TLR2 to PI3Kinase activation and phagocyte polarization. EMBO J 2009; 28:2018-2027.
34. Depaolo RW, Tang F, Kim I, et al. Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis. Cell Host Microbe 2008; 4:350-361.
35. Farhat K, Riekenberg S, Heine H, et al. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. J Leukoc Biol 2008; 83:692-701. (Pubitemid 351966879)
36. Kenny EF, Talbot S, Gong M, Golenbock DT, Bryant CE, O'Neill LA. MyD88 adaptor-like is not essential for TLR2 signaling and inhibits signaling by TLR3. J Immunol 2009; 183:3642-3651.
37. Keck S, Freudenberg M, Huber M. Activation of murine macrophages via TLR2 and TLR4 is negatively regulated by a Lyn/PI3K module and promoted by SHIP1. J Immunol 2010; 184:5809-5818.
38. Zhou D, Collins CA, Wu P, Brown EJ. Protein tyrosine phosphatase SHP-1 positively regulates TLR-induced IL-12p40 production in macrophages through inhibition of phosphatidylinositol 3-kinase. J Leukoc Biol 2010; 87:845-855.
39. Kahnert A, Seiler P, Stein M, et al. Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. Eur J Immunol 2006; 36:631-647.
40. Shirey KA, Cole LE, Keegan AD, Vogel SN. Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism. J Immunol 2008; 181:4159-4167.
41. Shirey KA, Pletneva LM, Puche AC, et al. Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependent. Mucosal Immunol 2010; 3:291-300.
42. Varin A, Mukhopadhyay S, Herbein G, Gordon S. Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion. Blood 2010; 115:353-362.
43. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009; 27:451-483.
44. Cho JS, Pietras EM, Garcia NC, et al. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest 2010; 120:1762-1773.
45. Holland SM, DeLeo FR, Elloumi HZ, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007; 357:1608-1619. (Pubitemid 47598403)